Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,516
Closed -$12.4K 11041
2025
Q1
$12.4K Sell
30,516
-94,157
-76% -$60.4K ﹤0.01% 9182
2024
Q4
$82.5K Sell
124,673
-79,662
-39% -$55.3K ﹤0.01% 8825
2024
Q3
$173K Buy
+204,335
New +$156K ﹤0.01% 8736
2024
Q2
Sell
-135,595
Closed -$113K 10260
2024
Q1
$176K Buy
135,595
+114,073
+530% +$120K ﹤0.01% 8260
2023
Q4
$12.3K Sell
21,522
-20,392
-49% -$14.1K ﹤0.01% 8952
2023
Q3
$31.6K Sell
41,914
-162,964
-80% -$124K ﹤0.01% 8237
2023
Q2
$150K Buy
+204,878
New +$190K ﹤0.01% 7814
2023
Q1
Sell
-882,456
Closed -$848K 10024
2022
Q4
$848K Buy
882,456
+702,258
+390% +$993K ﹤0.01% 5235
2022
Q3
$393K Buy
180,198
+32,338
+22% +$112K ﹤0.01% 7135
2022
Q2
$517K Buy
147,860
+75,699
+105% +$283K ﹤0.01% 6682
2022
Q1
$365K Sell
72,161
-8,425
-10% -$42.7K ﹤0.01% 8055
2021
Q4
$505K Sell
80,586
-44,523
-36% -$304K ﹤0.01% 7257
2021
Q3
$994K Buy
125,109
+23,539
+23% +$194K ﹤0.01% 5918
2021
Q2
$761K Buy
101,570
+38,412
+61% +$268K ﹤0.01% 6422
2021
Q1
$383K Sell
63,158
-271,727
-81% -$2.09M ﹤0.01% 7293
2020
Q4
$1.91M Buy
334,885
+224,086
+202% +$1.43M ﹤0.01% 3564
2020
Q3
$736K Sell
110,799
-94,378
-46% -$841K ﹤0.01% 4588
2020
Q2
$1.81M Buy
+205,177
New +$589K ﹤0.01% 3201
2014
Q3
Sell
-3,473
Closed -$108K 3114
2014
Q2
$108K Sell
3,473
-85
-2% -$3.55K ﹤0.01% 2347
2014
Q1
$239K Buy
+3,558
New +$220K ﹤0.01% 2205

Other funds holding VXRT

Jane Street's VXRT Position: Q2 2025 in Review

Jane Street sold out of Vaxart (VXRT) in Q2 2025, closing a stake of 30,516 shares — an estimated $12.4K sold.

Jane Street first reported a position in VXRT in Q1 2014 and held it in 20 quarters. The position peaked at $1.91M in Q4 2020. 98 funds tracked by Wall St. Rank hold VXRT as of Q2 2025.

  • Jane Street reported no remaining Vaxart position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 30,516 Vaxart shares in Q2 2025, an estimated $12.4K.
  • Jane Street first reported a position in Vaxart in Q1 2014 and held it in 20 quarters.
  • Jane Street's Vaxart position peaked at $1.91M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Vaxart as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.